drugset / Trial / NCT05613361

The Effect of Curcumin Against Colistin-induced Nephrotoxicity

NCT05613361

Phase 3 Unknown 214 enrolled October 6 University Cairo University · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

The goal of this study is to investigate the possible nephroprotective effect of curcumin in critically ill patients receiving colistin.

Timeline

Start
2023-01-01
Primary completion
2024-04-30
Completion
2024-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Curcumin Small molecule 1 g Oral
Background Colistin Other / unclassified 4.5e+06 iu Intravenous

Indications